Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2015

  1. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: A promising approach for the treatment of defective telomerase disorders

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 91, pp. 91-102

  2. Specific requirements for somatic cell therapy medicinal products and tissue engineered products

    Pharmaceuticals Policy and Law, Vol. 17, Núm. 1-2, pp. 271-277

  3. Specific requirements regarding module 5

    Pharmaceuticals Policy and Law, Vol. 17, Núm. 1-2, pp. 279-281

2006

  1. PMSE 309-F MALDI TOF MS of group IVA polymers containing acyclovir

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

2005

  1. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules

    Molecular Therapy, Vol. 12, Núm. 2, pp. 283-289